Revenue Growth QoQ: OraSure (OSUR)

Symbol and logo of brand OraSure Technologies Inc (OSUR)

OraSure Technologies (OSUR) dominates the rapid diagnostics segment thanks to its patents for home tests. The business relies on government contracts and the trend toward molecular saliva analysis. The quarterly revenue trend shows that the parameter value is 14.20. However, post-pandemic product commoditization is eroding margins, forcing the company to implement expensive specialized devices to protect profits.

OraSure Technologies Inc (OSUR) - Quarterly Revenue Growth from 07/04/2022 to 11/20/2026

Analytical breakdowns and data insights for company OraSure Technologies Inc (OSUR)

- stock price and consensus target price:
- company stock exchange capitalization indicators:
General company analysis:OraSure Technologies Inc - OSUR
Manufactured products of OraSure Technologies, Inc.

For OraSure Technologies (OSUR), which distributes rapid tests through pharmacy chains, quarterly revenue growth serves as an indicator of operational efficiency amid cyclical demand. This metric measures the percentage change in sales volume for the current quarter compared to the same period last year, neutralizing seasonal fluctuations. By analyzing the percentage increase in quarterly sales, an investor assesses the pace of business scaling relative to historical data. Diversified logistics and raw material buffer stocks ensure the stability of this indicator, protecting profitability from external shocks.

Who OraSure Technologies competes with

A - Revenue Growth QoQ|Quarterly Sales Growth Rate Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Quarterly Sales Growth|Quarterly Sales Growth Cologuard|RVTY (Revvity Corp) - Quarterly Revenue Growth|Quarterly Revenue Growth Bio-Rad Laboratories Inc|Quarterly Sales Growth NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Quarterly Revenue Increase|Revenue Growth QoQ QuidelOrtho Inc. QDEL|Quarterly Revenue Growth OPKO Health Inc OPK|CareDx Inc - Quarterly Revenue Growth|Quarterly Revenue Increase MRVI (Maravai)|FLGT: Quarterly Revenue Growth|LAB (Standard BioTools Inc.) - Revenue Growth QoQ|Revenue Growth QoQ Cytek Biosciences Inc|Exagen (XGN) - Quarterly Sales Growth Rate|Revenue Growth QoQ MDxHealth, Inc. (MDXH)|Lucid Diagnostics, Inc - Sales Growth QoQ|Revenue Growth QoQ Prenetics PRE|Insight Molecular (IMDX) - Quarterly Revenue Growth Rate|Trinity Biotech Corp - Quarterly Revenue Growth|Quarterly Sales Growth Rate ProPhase PRPH|AIMD: Quarterly Revenue Growth|CODX - Quarterly Sales Growth Rate|Revenue Growth QoQ Heart Test Laboratories, Inc.|Revenue Growth QoQ BMRA|Quarterly Revenue Growth CDIO|Onconetix - Sales Growth QoQ|Revenue Growth QoQ viraxbiolabs.com VRAX|Quarterly Sales Growth Rate Bluejay (BJDX)|AWH: Quarterly Sales Growth|Quarterly Sales Growth Rate Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Revenue Growth QoQ|Revenue Dynamics QoQ ENZ (Enzo)|Sales Growth QoQ Fresh2 (FRES)|Genetic Technologies (GENE) - Quarterly Sales Growth Rate|Quarterly Revenue Growth ME|Revenue Growth QoQ PMD (Psychemedics Corporation)